Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 DiabetesVlado Perkovic, Richard Pratley, Florian M.M. Baeres et al.|New England Journal of Medicine|2024Cited by 1.5k
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trialJohannes F.E. Mann, Katherine R. Tuttle, Peter Rossing et al.|Nature Medicine|2024Cited by 152
Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26‐week, open‐label, randomized, active comparator clinical trialLi Zang, Yimin Mu, Ying‐Ying Liu et al.|Diabetes Obesity and Metabolism|2016Cited by 42